Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Filshie

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
BMJ (Clinical Research Ed.)|October 21, 1995
Inserting central venous catheters. Difficulties are rare and do not correlate with lifespan of catheterJ Filshie, C Nightingale, P Wood, et al.
British Journal of Clinical Pharmacology|April 1, 1989
The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteersP J Hoskin, G W Hanks, G W Aherne, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2016
A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesotheliomaA Minchom, R Punwani, J Filshie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2013
A randomized, controlled trial of acupuncture self-needling as maintenance therapy for cancer-related fatigue after therapist-delivered acupunctureA Molassiotis, J Bardy, J Finnegan-John, et al.
Leukemia|April 7, 1998
MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignanciesR J Filshie, A C Zannettino, V Makrynikola, et al.
British Journal of Cancer|September 1, 1983
Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantationM A Cornbleet, T J McElwain, P J Kumar, et al.
Leukemia|September 3, 2010
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCRD M Ross, S Branford, J F Seymour, et al.
Blood|May 25, 2013
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER studyDavid M Ross, Susan Branford, John F Seymour, et al.
Lancet (London, England)|March 19, 1983
Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemiaR L Powles, G R Morgenstern, H E Kay, et al.
Leukemia|October 14, 2018
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cellsDavid M Ross, Ilaria S Pagani, Naranie Shanmuganathan, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
BMJ (Clinical Research Ed.)|October 21, 1995
Inserting central venous catheters. Difficulties are rare and do not correlate with lifespan of catheterJ Filshie, C Nightingale, P Wood, et al.
British Journal of Clinical Pharmacology|April 1, 1989
The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteersP J Hoskin, G W Hanks, G W Aherne, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2016
A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesotheliomaA Minchom, R Punwani, J Filshie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2013
A randomized, controlled trial of acupuncture self-needling as maintenance therapy for cancer-related fatigue after therapist-delivered acupunctureA Molassiotis, J Bardy, J Finnegan-John, et al.
Leukemia|April 7, 1998
MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignanciesR J Filshie, A C Zannettino, V Makrynikola, et al.
British Journal of Cancer|September 1, 1983
Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantationM A Cornbleet, T J McElwain, P J Kumar, et al.
Leukemia|September 3, 2010
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCRD M Ross, S Branford, J F Seymour, et al.
Blood|May 25, 2013
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER studyDavid M Ross, Susan Branford, John F Seymour, et al.
Lancet (London, England)|March 19, 1983
Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemiaR L Powles, G R Morgenstern, H E Kay, et al.
Leukemia|October 14, 2018
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cellsDavid M Ross, Ilaria S Pagani, Naranie Shanmuganathan, et al.
Pageof 4